Search Results
AlloSCT outcomes from younger matched unrelated donor versus older sibling donor for AML
Younger matched unrelated donor vs. older matched sibling donor for alloSCT in patients with B-ALL
Young matched unrelated donors versus older-aged matched sibling donors in alloSCT with PTCy
How donor age impacts outcomes in patients with AML undergoing alloSCT
HSCT in AML: matched siblings versus haploidentical donors
Factors to consider when selecting mismatched unrelated donors for stem cell transplantation
MRD vs MUD vs haploidentical alloHSCT in patients with AML who achieve CR after 2 induction courses
Optimising transplant outcome in adults allografted for AML
AML 60-80 years: Who should get an allo transplant?
Webinar: Stem Cell Transplants for AML What You Need to Know 2016
Indications for allogeneic stem cell transplantation in AML
AML Indications for Transplantation and Treatment of Relapse
